Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroglia | 6 | 2025 | 204 | 2.870 |
Why?
|
| C9orf72 Protein | 6 | 2019 | 24 | 2.740 |
Why?
|
| Lipid Droplets | 4 | 2025 | 46 | 2.160 |
Why?
|
| DNA Repeat Expansion | 6 | 2019 | 64 | 1.710 |
Why?
|
| Frontotemporal Dementia | 5 | 2019 | 43 | 1.690 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2019 | 149 | 1.530 |
Why?
|
| Alzheimer Disease | 4 | 2025 | 800 | 1.230 |
Why?
|
| Neurons | 8 | 2025 | 1932 | 0.990 |
Why?
|
| Lipid Metabolism | 2 | 2024 | 357 | 0.910 |
Why?
|
| Sleep | 2 | 2024 | 345 | 0.890 |
Why?
|
| tau Proteins | 1 | 2024 | 207 | 0.770 |
Why?
|
| Oxidative Stress | 2 | 2024 | 835 | 0.750 |
Why?
|
| beta Karyopherins | 1 | 2021 | 12 | 0.750 |
Why?
|
| ran GTP-Binding Protein | 1 | 2021 | 28 | 0.740 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 32 | 0.740 |
Why?
|
| Karyopherins | 1 | 2021 | 36 | 0.730 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2021 | 71 | 0.700 |
Why?
|
| Dipeptides | 3 | 2019 | 56 | 0.690 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2521 | 0.660 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2019 | 35 | 0.630 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 369 | 0.600 |
Why?
|
| Parkinson Disease | 1 | 2024 | 690 | 0.540 |
Why?
|
| Drosophila | 7 | 2024 | 774 | 0.520 |
Why?
|
| Drosophila Proteins | 2 | 2021 | 714 | 0.520 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 499 | 0.520 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 712 | 0.510 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1700 | 0.470 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 1265 | 0.450 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1056 | 0.440 |
Why?
|
| Transcription Factors | 3 | 2019 | 2588 | 0.430 |
Why?
|
| Animals | 14 | 2025 | 34220 | 0.330 |
Why?
|
| Drosophila melanogaster | 3 | 2021 | 769 | 0.260 |
Why?
|
| RNA | 2 | 2019 | 570 | 0.250 |
Why?
|
| Clusterin | 1 | 2025 | 11 | 0.240 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 4393 | 0.240 |
Why?
|
| Astrocytes | 2 | 2025 | 249 | 0.240 |
Why?
|
| Cell Communication | 1 | 2025 | 166 | 0.230 |
Why?
|
| Glucosylceramidase | 1 | 2024 | 27 | 0.230 |
Why?
|
| Coculture Techniques | 1 | 2024 | 226 | 0.220 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 662 | 0.220 |
Why?
|
| Exocytosis | 1 | 2023 | 63 | 0.200 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 573 | 0.200 |
Why?
|
| Alleles | 3 | 2025 | 1615 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 167 | 0.190 |
Why?
|
| Lysosomes | 1 | 2023 | 237 | 0.180 |
Why?
|
| Humans | 15 | 2025 | 125090 | 0.180 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 312 | 0.170 |
Why?
|
| Cells, Cultured | 2 | 2024 | 3054 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 250 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 658 | 0.170 |
Why?
|
| GC Rich Sequence | 1 | 2019 | 6 | 0.170 |
Why?
|
| Sequence Alignment | 1 | 2021 | 621 | 0.170 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 213 | 0.160 |
Why?
|
| Brain | 2 | 2024 | 2999 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 281 | 0.160 |
Why?
|
| Gene Dosage | 1 | 2021 | 440 | 0.160 |
Why?
|
| RNA Polymerase II | 1 | 2019 | 100 | 0.160 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 663 | 0.160 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 221 | 0.160 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2018 | 7 | 0.150 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 33 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 889 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3716 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2018 | 133 | 0.140 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2715 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1005 | 0.130 |
Why?
|
| Peptides | 1 | 2019 | 811 | 0.130 |
Why?
|
| Genome, Human | 1 | 2021 | 1272 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 725 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 113 | 0.110 |
Why?
|
| Glioma | 1 | 2018 | 492 | 0.110 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 48 | 0.110 |
Why?
|
| Myotonic Dystrophy | 1 | 2014 | 149 | 0.100 |
Why?
|
| Mice | 5 | 2025 | 17634 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 813 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2013 | 459 | 0.090 |
Why?
|
| Proteins | 1 | 2016 | 1036 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2013 | 330 | 0.080 |
Why?
|
| Female | 6 | 2021 | 66748 | 0.080 |
Why?
|
| Male | 5 | 2021 | 61470 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8205 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 5849 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 359 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 1687 | 0.060 |
Why?
|
| Infant | 1 | 2021 | 12477 | 0.060 |
Why?
|
| Lipid Peroxides | 1 | 2023 | 15 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 194 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2023 | 97 | 0.050 |
Why?
|
| Iron | 1 | 2023 | 270 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 2047 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 163 | 0.040 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2018 | 19 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2019 | 138 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 105 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 272 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 698 | 0.030 |
Why?
|
| Eye | 1 | 2018 | 227 | 0.030 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 25 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 868 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2634 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 223 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 76 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 278 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 84 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4534 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 66 | 0.030 |
Why?
|
| Stem Cells | 1 | 2018 | 706 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2821 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 398 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 352 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 677 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3348 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 388 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 779 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 683 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1561 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4813 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 676 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1112 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 954 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1711 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1896 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 1893 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 4263 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 4637 | 0.010 |
Why?
|